Literature DB >> 35369368

Serum Transaminases at Presentation and Association with Acute Dialysis in Children with Hemolytic Uremic Syndrome.

Saurabh Talathi1, Margaux Barnes2, Inmaculada Aban3, Reed Dimmitt2, David J Askenazi4.   

Abstract

Background: To determine whether serum transaminases at presentation predict the need for dialysis in children with hemolytic uremic syndrome (HUS).
Methods: Single-center, retrospective chart review of pediatric patients with HUS. Data collected included demographics, clinical and laboratory parameters, and need for dialysis. These factors were compared between two groups: "dialysis" versus "no dialysis." Continuous data were compared using a t test whereas categoric data were compared by the chi-squared test. Multivariate logistic regression was performed on a prior set of variables to determine if serum transaminases independently predict the need for dialysis.
Results: A total of 70 children were included in the study, of which, 39 (27%) received dialysis. The no-dialysis group had a higher proportion of white patients compared with the dialysis group (74% dialysis versus 94% no dialysis). The only clinical sign at admission associated with dialysis was reduced urine output (56% versus 16%, P<0.001). Univariate logistic regression identified admission serum creatinine, aspartate transaminase (AST), and alanine transaminase (ALT) to be associated with the need for dialysis. Multivariate logistic regression showed serum AST and ALT to be independent predictors of the need for dialysis, with both improving the performance of the regression model. Sensitivity analysis showed a cutoff of 129 U/L for AST and 83 U/L for ALT with high specificity. Conclusions: Serum transaminases at presentation are independently associated with the subsequent need for dialysis in patients with HUS. Our study suggests that when both serum ALT and AST are normal, the likelihood to need dialysis is very low; alternatively, when both serum ALT and AST are more than two times the upper level of normal, the need for dialysis is very high.
Copyright © 2020 by the American Society of Nephrology.

Entities:  

Keywords:  GI manifestations; HUS; STEC; acute kidney injury; acute kidney injury and ICU nephrology; dialysis; hemolytic uremic syndrome; liver enzymes; renal insufficiency; severity

Mesh:

Substances:

Year:  2020        PMID: 35369368      PMCID: PMC8809299          DOI: 10.34067/KID.0000222020

Source DB:  PubMed          Journal:  Kidney360        ISSN: 2641-7650


  21 in total

1.  Postdiarrheal hemolytic uremic syndrome in United States children: clinical spectrum and predictors of in-hospital death.

Authors:  Rajal K Mody; Weidong Gu; Patricia M Griffin; Timothy F Jones; Josh Rounds; Beletshachew Shiferaw; Melissa Tobin-D'Angelo; Glenda Smith; Nancy Spina; Sharon Hurd; Sarah Lathrop; Amanda Palmer; Effie Boothe; Ruth E Luna-Gierke; Robert M Hoekstra
Journal:  J Pediatr       Date:  2015-02-04       Impact factor: 4.406

2.  KDIGO clinical practice guidelines for acute kidney injury.

Authors:  Arif Khwaja
Journal:  Nephron Clin Pract       Date:  2012-08-07

3.  Preeclampsia-induced Liver Dysfunction, HELLP syndrome, and acute fatty liver of pregnancy.

Authors:  Ghassan M Hammoud; Jamal A Ibdah
Journal:  Clin Liver Dis (Hoboken)       Date:  2014-09-26

Review 4.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.

Authors:  Carla Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2010-04-28       Impact factor: 3.714

Review 5.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  Risk factors for developing severe clinical course in HUS patients: a national survey in Japan.

Authors:  Ichiro Kamioka; Kunihiko Yoshiya; Kenichi Satomura; Hiroshi Kaito; Teruo Fujita; Kazumoto Iijima; Koichi Nakanishi; Norishige Yoshikawa; Kandai Nozu; Masafumi Matsuo
Journal:  Pediatr Int       Date:  2008-08       Impact factor: 1.524

7.  Incidence and index of severity of hemolytic uremic syndrome in a 26 year period in Fukushima Prefecture, Japan.

Authors:  Yukihiko Kawasaki; Kazuhide Suyama; Ryo Maeda; Eichi Yugeta; Kei Takano; Shigeo Suzuki; Hiroko Sakuma; Kenji Nemoto; Tomoko Sato; Katsutoshi Nagasawa; Mitsuaki Hosoya
Journal:  Pediatr Int       Date:  2014-02       Impact factor: 1.524

8.  Dehydration upon admission is a risk factor for incomplete recovery of renal function in children with haemolytic uremic syndrome.

Authors:  José M Ojeda; Isolda Kohout; Eduardo Cuestas
Journal:  Nefrologia       Date:  2013-04-05       Impact factor: 2.033

9.  Hyponatremia: a new predictor of mortality in patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.

Authors:  Laura F Alconcher; Paula A Coccia; Angela Del C Suarez; Marta L Monteverde; María Graciela Perez Y Gutiérrez; Paula M Carlopio; Mabel L Missoni; Alejandro Balestracci; Illiana Principi; Flavia B Ramírez; Patricia Estrella; Susana Micelli; Daniela C Leroy; Nahir E Quijada; Claudia Seminara; Marta I Giordano; Susana B Hidalgo Solís; Mariana Saurit; Alejandra Caminitti; Andrea Arias; Marta Rivas; Paula Risso; Miguel Liern
Journal:  Pediatr Nephrol       Date:  2018-06-30       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.